Renal hemodialysis and maternal serum triple analyte screening

Fetal Diagnosis and Therapy

Volumn 13, Issue 1, 1998, Pages 26-28

  Shulman, Lee P ^a   Briggs, Rodney ^a   Phillips, Owen P ^a   Friedman, Steven A ^a   Sibai, Baha ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Dialysis; Maternal serum screening; Renal disease

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MATERNAL SERUM; MORBIDITY; OBSTETRICS; PRIORITY JOURNAL; SCREENING;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; CHRONIC DISEASE; ESTRIOL; FEMALE; GLOMERULONEPHRITIS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RENAL DIALYSIS;

EID: 0031896401     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020796     Document Type: Article

References (4)

1. ACOG Committee on Obstetric Practice: Down syndrome screening. American College of Obstetricians and Gynecologists Committee Opinions, 1994, vol 141, pp 1-4.
2. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL: Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG and unconjugated estriol: A prospective 2-year study. Obstet Gynecol 1992;80:353-358.
3. Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA, Saller DN, Blitzer MG, Dickennan LH, Fisher R, et al: Risk based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chononic gonadotropin. Prenat Diagn 1995;15:713-723.
4. Lye WC, Tambyah P, Leong SO, Lee EJ: Serum tumor markers in patients on dialysis and kidney transplantation. Adv Periton Dial 1994;10:109-111.